Peer Review reports
From: Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
| Original Submission | ||
|---|---|---|
| 19 Feb 2024 | Submitted | Original manuscript |
| 1 Mar 2024 | Author responded | Author comments - Rosemina Bahrololoom |
| Resubmission - Version 2 | ||
| 1 Mar 2024 | Submitted | Manuscript version 2 |
| 10 Mar 2024 | Reviewed | Reviewer Report - Nicola Capasso |
| 11 Mar 2024 | Reviewed | Reviewer Report - Anna Vanni |
| 13 May 2024 | Author responded | Author comments - Rosemina Bahrololoom |
| Resubmission - Version 3 | ||
| 13 May 2024 | Submitted | Manuscript version 3 |
| 21 May 2024 | Author responded | Author comments - Rosemina Bahrololoom |
| Resubmission - Version 4 | ||
| 21 May 2024 | Submitted | Manuscript version 4 |
| 27 May 2024 | Reviewed | Reviewer Report - Anna Vanni |
| 6 Jun 2024 | Author responded | Author comments - Rosemina Bahrololoom |
| Resubmission - Version 5 | ||
| 6 Jun 2024 | Submitted | Manuscript version 5 |
| Publishing | ||
| 7 Jun 2024 | Editorially accepted | |
| 19 Jun 2024 | Article published | 10.1186/s12865-024-00628-w |
You can find further information about peer review here.